Moonshot Closes the Book on Private Markets: Final Round Lands at $50B, Hong Kong IPO of Up to $5B Eyes Q1 2027

Moonshot AI, the Beijing lab behind the Kimi family of models, has closed its final private funding round at a $50 billion valuation, according to sources cited by Bloomberg — and the company is now aiming its long-teased Hong Kong IPO at a raise of as much as $5 billion, with listing targeted for the first quarter of 2027. If the float lands anywhere near that size, it will be one of the largest AI-sector listings in Hong Kong’s history and the definitive test of whether global public-market investors will underwrite China’s frontier-model story at scale.

The round that kept re-rating

What makes the $50 billion figure striking is not just its size but its trajectory. Moonshot’s valuation history over the past twelve months reads like a case study in AI froth turning into conviction:

• December 2025: $500 million Series C at a $4.3 billion valuation
• February 2026: Reports of a new raise at ~$10 billion
• March–June 2026: A $1–2 billion pre-IPO process talked at $18–30 billion
• May 2026: Confirmed $2 billion raise at a $20 billion valuation
• July 29, 2026: A $3.5 billion round closes at $35 billion — triple the value in roughly six months
• October 2026: Final private round closes at $50 billion, ahead of the HKEX filing

That is a more-than-tenfold re-rating in under a year, driven almost entirely by one product event: the release of Kimi K3 in July 2026.

Kimi K3: the asset behind the number

Kimi K3 is the largest open-weight model ever released — a 2.8 trillion-parameter mixture-of-experts system with roughly 104 billion parameters active per token, a 1-million-token context window, and a Modified MIT license that permits commercial use. At launch it posted top-three results among open models on several frontier benchmarks, including a 91.2% score that made the rounds on launch day, and it carries aggressive API pricing in the single-digit dollars per million input tokens.

The release mattered for two reasons. First, it put a Chinese lab at the outright frontier of open-weight scaling — a category Western labs have largely vacated as they chase proprietary, API-gated flagships. Second, it converted directly into revenue. Reporting through the summer pegged Moonshot’s revenue run rate at around $300 million and climbing, with Kimi K3’s open weights acting as a distribution engine for Moonshot’s paid API and enterprise products. That revenue line is what allowed underwriters to pitch the $50 billion private price to public-market investors.

The Hong Kong gambit

Moonshot confidentially filed for the Hong Kong listing in early September 2026, with Reuters and the Wall Street Journal both confirming the filing and the $3 billion-plus raise target at the time. Since then, the target has reportedly been sized up to as much as $5 billion, with an earliest listing window in Q4 2026 and a more conservative aim of Q1 2027 — the timeline that now appears to be the base case.

Two structural details are worth watching:

The offshore structure unwind. Earlier in 2026, Moonshot began removing the offshore holding structure that had allowed foreign investors to hold shares — a restructuring that suggests the company is optimizing for a mainland-and-Hong Kong investor base rather than a US one. Alibaba, Tencent, and IDG Capital are among the notable existing backers.

The DeepSeek shadow. Moonshot is not the only Chinese AI lab queuing for public markets. DeepSeek has tapped CITIC Securities for a domestic (A-share) IPO, and the wider cohort of “AI tigers” — Zhipu, MiniMax, and others — are expected to follow. Moonshot’s float will set the pricing benchmark for all of them.

Why it matters

The $50 billion private close is the market’s verdict on open-weight strategy as a business. For two years the consensus was that giving away frontier weights was a charity operation — good for developer relations, bad for defensibility. Moonshot’s K3 gambit inverted that: open weights as global distribution, monetized through hosted inference and enterprise contracts, with a public listing as the exit liquidity.

It also marks a milestone for Hong Kong itself. The exchange spent 2026 rebuilding its position as the venue for Chinese tech flotations after a bruising few years, and AI deal flow was the engine — Hong Kong’s Q3 2026 fundraising hit a record on the back of AI-related listings. A $5 billion Moonshot IPO in Q1 2027 would be the exchange’s largest pure-AI listing and a direct answer to the question of whether public markets, not just private crossover funds, will fund frontier-model training runs.

The risks are equally clear. A $50 billion valuation on a ~$300 million run rate is a revenue multiple well above anything public markets currently pay for software, let alone for a company whose flagship product is free to download. The bull case requires Kimi’s open-weight distribution to keep compounding into paid usage at frontier-lab economics. The bear case is that the same openness that built the brand makes the moat shallow — any competitor can fine-tune K3’s descendants and undercut on price.

Either way, the private chapter is closed. What happens next happens under a stock ticker.

Sources

• Bloomberg — China’s Moonshot in Talks on Pre-IPO Funds at $50 Billion Value
• Reuters — Chinese AI firm Moonshot files confidentially for Hong Kong IPO
• Caproasia — Moonshot AI Files Hong Kong IPO to Raise $5 Billion at Over $50 Billion Valuation
• Bloomberg — Moonshot AI Passes Funding Goal to Hit $35 Billion Value
• Kimi — Kimi K3 Technical Blog